Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Risperdal Kickback Case: J&J Tried to Freeze Out Lilly; 72% Market Share Not Good Enough!
Risperdal Kickback Case: J&J Tried to Freeze Out Lilly; 72% Market Share Not Good Enough!
Risperdal Kickback Case: J&J Tried to Freeze Out Lilly; 72% Market Share Not Good Enough!
Submitted by
admin
on January 20, 2010 - 10:38am
Source:
BNET Pharma
News Tags:
Risperdal
kickbacks
JNJ
Eli Lilly
Headline:
Risperdal Kickback Case: J&J Tried to Freeze Out Lilly; 72% Market Share Not Good Enough!
Do Not Allow Advertisers to Use My Personal information
